| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |